Literature DB >> 3813959

Intraocular pressure effects of multiple doses of drugs applied to glaucomatous monkey eyes.

P Y Lee, S M Podos, J B Serle, C B Camras, C H Severin.   

Abstract

The effects of multiple dosing with 0.5% timolol maleate, 2% epinephrine hydrochloride, 4% pilocarpine hydrochloride, 1% vanadate, 1% forskolin (nonproprietary name, colforsin), or 0.5% prostaglandin F2 alpha on intraocular pressure (IOP) were each tested on eight cynomolgus monkey eyes in which glaucoma was induced by photocoagulating the trabecular meshwork with the argon laser. The week prior to drug therapy, baseline IOP measurements were carried out at hourly intervals from 9:30 am to 3:30 pm on three days. One to two days later, therapy was initiated. Each drug was applied topically to both eyes of each monkey twice daily for at least four days. The IOP was measured with a calibrated pneumatonometer at the same hourly intervals on treatment days as on the baseline days. The IOP at each time of day on treatment days was compared with the average baseline IOP measured at the corresponding time of day. Topical application of timolol, epinephrine, pilocarpine, vanadate, and prostaglandin F2 alpha significantly reduced IOP without evidence of tolerance or tachyphylaxis during the course of therapy. Forskolin did not significantly decrease IOP after the second day of treatment.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3813959     DOI: 10.1001/archopht.1987.01060020103038

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  7 in total

1.  The role of prostaglandins in the para-aminoclonidine-induced reduction of intraocular pressure.

Authors:  R F Wang; C B Camras; S M Podos; K W Lee; K C Bhuyan; D K Bhuyan
Journal:  Trans Am Ophthalmol Soc       Date:  1989

2.  Sodium orthovanadate effect on outflow facility and intraocular pressure in live monkeys.

Authors:  James C H Tan; Julie A Kiland; Jose M Gonzalez; B'Ann T Gabelt; Donna M Peters; Paul L Kaufman
Journal:  Exp Eye Res       Date:  2010-07-08       Impact factor: 3.467

3.  L-662,583 is a topically effective ocular hypotensive carbonic anhydrase inhibitor in experimental animals.

Authors:  M F Sugrue; P Gautheron; P Mallorga; T E Nolan; S L Graham; H Schwam; K L Shepard; R L Smith
Journal:  Br J Pharmacol       Date:  1990-01       Impact factor: 8.739

4.  Evaluation of rebound tonometry in non-human primates.

Authors:  Elizabeth J Elsmo; Julie A Kiland; Paul L Kaufman; Gillian J McLellan
Journal:  Exp Eye Res       Date:  2011-02-16       Impact factor: 3.467

5.  Morphological changes to Schlemm's canal and the distal aqueous outflow pathway in monkey eyes with laser-induced ocular hypertension.

Authors:  Shayna Sosnowik; David L Swain; Shan Fan; Carol B Toris; Haiyan Gong
Journal:  Exp Eye Res       Date:  2022-03-10       Impact factor: 3.770

6.  Characterization of intraocular pressure responses of the Tibetan monkey (Macaca thibetana).

Authors:  Guo Liu; Tao Zeng; Wenhan Yu; Naihong Yan; Hongxing Wang; Su-ping Cai; Iok-Hou Pang; Xuyang Liu
Journal:  Mol Vis       Date:  2011-05-27       Impact factor: 2.367

7.  Endothelial Glycocalyx Morphology in Different Flow Regions of the Aqueous Outflow Pathway of Normal and Laser-Induced Glaucoma Monkey Eyes.

Authors:  Shayna Sosnowik; David L Swain; Neil Liu; Shan Fan; Carol B Toris; Haiyan Gong
Journal:  Cells       Date:  2022-08-07       Impact factor: 7.666

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.